Use of Statins in Patients with Insulin-Treated Type 2 Diabetes (T2D): Associations with Glycemic Control and Mortality Risks

被引：0
|
作者：
Anyanwagu, Uchenna C.
Mamza, Jil B.
Idris, Iskandar
Donnelly, Richard
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1619-P
引用
收藏
页码：A433 / A433
页数：1
相关论文
共 50 条
  • [21] Association between HbA1c with Cardiovascular (CV) Events and All-Cause Mortality in Elderly Patients with Insulin-treated Type 2 Diabetes (T2D)
    Anyanwagu, Uchenna C.
    Mamza, Jil B.
    Mehta, Rajnikant
    Donnelly, Richard
    Idris, Iskandar
    DIABETES, 2016, 65 : A368 - A368
  • [22] Hypoglycemia, Glycemic Variability, and Risk of Cardiac Arrhythmias in Insulin-Treated Patients with Type 2 Diabetes
    Andersen, Andreas
    Bagger, Jonatan I.
    Sorensen, Samuel K.
    Baldassarre, Maria Pompea Antonia
    Pedersen-Bjergaard, Ulrik
    Forman, Julie
    Gislason, Gunnar
    Lindhardt, Tommi B.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES, 2021, 70
  • [23] Canagliflozin Improves Glycemic Control in Subjects with Type 2 Diabetes (T2D) Not Optimally Controlled on Stable Doses of Insulin
    Schwartz, Sherwyn
    Morrow, Linda
    Hompesch, Marcus
    Devineni, Damayanthi
    Skee, Donna
    Vandebosch, An
    Murphy, Joe
    Pfeifer, Michael
    DIABETES, 2010, 59 : A154 - A154
  • [24] Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study
    Andreas Andersen
    Jonatan I. Bagger
    Samuel K. Sørensen
    Maria P. A. Baldassarre
    Ulrik Pedersen-Bjergaard
    Julie L. Forman
    Gunnar Gislason
    Tommi B. Lindhardt
    Filip K. Knop
    Tina Vilsbøll
    Cardiovascular Diabetology, 20
  • [25] Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study
    Andersen, Andreas
    Bagger, Jonatan, I
    Sorensen, Samuel K.
    Baldassarre, Maria P. A.
    Pedersen-Bjergaard, Ulrik
    Forman, Julie L.
    Gislason, Gunnar
    Lindhardt, Tommi B.
    Knop, Filip K.
    Vilsboll, Tina
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [26] Amputations and mortality in elderly insulin-treated patients with type 2 diabetes - Invited commentary
    Schweiger, H
    ZENTRALBLATT FUR CHIRURGIE, 1999, 124 (06): : 507 - 507
  • [27] Pioglitazone (PIO) is superior to gliclazide (GLIC) in sustaining glycemic control in patients with type 2 diabetes (T2D)
    Tan, M
    Johns, D
    Urquhart, R
    Voet, B
    Mariz, S
    Mattoo, V
    DIABETES, 2004, 53 : A147 - A147
  • [28] The Impact of Glucose Variability on Achievement of Glycemic Control and Risk of Hypoglycemia in Patients with Type 2 Diabetes (T2D)
    Umpierrez, Guillermo E.
    Digenio, Andres
    Zhou, Rong
    Inzucchi, Silvio
    DIABETES, 2011, 60 : A310 - A311
  • [29] Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes
    Si, Yiming
    Shen, Yun
    Lu, Jingyi
    Ma, Xiaojing
    Zhang, Lei
    Mo, Yifei
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Hu, Gang
    Zhou, Jian
    ENDOCRINE, 2020, 68 (01) : 116 - 123
  • [30] Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
    Meininger, Gary E.
    Scott, Russell
    Alba, Maria
    Yue Shentu
    Luo, Edmund
    Amin, Himal
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    DIABETES CARE, 2011, 34 (12) : 2560 - 2566
12345